Inission (INISS) Q1 & AGM 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 & AGM 2025 earnings summary
26 Nov, 2025Executive summary
Turnover for 2024 was SEK 2.15 billion, with a SEK 191 million drop in organic sales and a SEK 15 million drop in organic gross profit, mitigated by improved material share.
Q1 2025 sales declined 16.8% to SEK 483.6 million, with organic decline at 19.2%; EBITDA margin dropped to 4.1%.
Order intake rose to SEK 606.8 million from SEK 377.1 million year-over-year, and book-to-bill ratio improved to 1.3.
Cost reduction programs are ongoing, with annualized costs about SEK 10 million lower year-over-year and further reductions expected to show results by Q4.
Cash flow from operations in Q1 improved to SEK 34.2 million, supported by reduced working capital.
Financial highlights
EBITDA for 2024 declined by SEK 37 million; LTM EBITDA margin stands at 4.5%.
Q1 2025 EBITDA was SEK 20 million, with a significant drop in margin compared to last year.
Net income per share was SEK 0.1 in Q1 2025, compared to SEK 1.7 last year; 2024 profit per share was SEK 3.3.
Dividend of SEK 1 per share to be paid, in line with policy of up to 30% after tax.
Net debt increased to SEK 469.7 million; equity ratio at 38.9%.
Outlook and guidance
2025 targets: sales of SEK 2.2 billion, EBITDA/EBITA margin target of 6%, equity ratio above 30%, dividend up to 30% of net profit.
Management maintains guidance but notes increased uncertainty due to global macroeconomic risks, especially U.S. tariffs.
Order book is 23% higher year-over-year, but volume growth is approached cautiously as orders may stretch over a longer period.
Cost reduction programs are being intensified and expected to show results in Q2 and beyond.
Management expects cost reductions to restore profitability even if volumes remain at Q1 levels.
Latest events from Inission
- 2025 revenue rose to SEK 2,206.2 million, with strong cash flow and positive 2026 outlook.INISS
Q4 202520 Feb 2026 - Q2 sales up 1.4% to 570 MSEK, but organic growth and margins declined.INISS
Q2 202423 Jan 2026 - Sales and EBIT fell, but order intake and stability improved; guidance and cost base adjusted.INISS
Q3 202415 Jan 2026 - Revised targets and integration efforts position the company for renewed growth next year.INISS
ABGSC Investor Days11 Jan 2026 - Sales and margins fell, but order intake and cash flow rebounded; cost cuts and recovery expected.INISS
Q4 202426 Dec 2025 - Targeting 15% annual growth and 9% EBITDA margin, leveraging acquisitions and mega trends.INISS
CMD 202529 Nov 2025 - Sales fell 6.2%, but order intake, cash flow, and acquisitions signal H2 recovery.INISS
Q2 202523 Nov 2025 - Q3 sales and margins improved, EMS strong, Enedo restructuring, 2025 targets revised.INISS
Q3 20257 Nov 2025